The use of VOG as diagnostic, but also predictive or prognostic biomarker, could be addressed by further studies with larger sample sizes and longitudinal analysis of VOG findings, focusing on patients with anti-IglON5 disease without parkinsonian features but developing a PSP like phenotype over the course. Here, IGLON5 is linked to supranuclear palsy, progressive, 1.